PKPaul J. Kingham

Paul J. Kingham

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul J. Kingham has a total of 186 co-authors. Here are the top co-authors by number of shared publications:

  • Mikael Wiberg

    Laboratory of Neural Repair and Cellular Therapy, Department of Integrative Medical Biology (IMB), Umeå University, Umeå, Sweden

    29 shared publications
  • Giorgio Terenghi

    18 shared publications
  • Daniel Felix Kalbermatten

    Department of Plastic, Reconstructive and Aesthetic Surgery, Geneva University Hospitals, Geneva University, 1205 Geneva, Switzerland

    14 shared publications
  • Lev Novikov

    Department of Integrative Medical Biology, Umeå University, SE-901 87 Umeå, Sweden

    14 shared publications
  • G. Terenghi

    Blond McIndoe Laboratories, Tissue Injury and Repair Research Group, School of Clinical and Laboratory Sciences, University of Manchester, Manchester, UK

    9 shared publications
  • Liudmila N Novikova

    Laboratory of Neural Repair and Cellular Therapy, Department of Integrative Medical Biology, Umeå University, Umeå, Sweden

    8 shared publications

Latest Publications

  • Open Access

    Mesoporous Silicate–Calcium Phosphate Scaffolds Induce Osteogenesis and a Proangiogenic Secretome in Human Mesenchymal Stem Cells

    by Luis Oliveros Anerillas, Nick Moghbel, Fredric G. Svensson, Nils Gustafsson, Maria Vittoria Giraudo, Agnieszka Noszczyk-Nowak, Dominika Kubiak-Nowak, Marek Michalski, Dominika Stygar, Mikko J. Lammi, et al.

    Large bone defects remain a major clinical challenge because conventional calcium phosphate substitutes act as passive scaffolds and fail to actively couple osteogenesis with the vascularisation needed for durable repair. Here, we report a nanostructured silicate–calcium phosphate (nSCP) scaffold designed to integrate silicate bioactivity with calcium phosphate osteoconductivity in a single mesoporous architecture that actively reprograms host stem-cell behaviour. The material is produced by a scalable aqueous co-precipitation route in which a silicate backbone templates hydroxyapatite, tetracalcium phosphate and amorphous brushite-type domains, yielding a homogeneously dispersed nanostructure with a BET surface area of 321 m²/g and a dominant pore diameter of ~4 nm. In a 3D collagen hydrogel model with human bone-marrow mesenchymal stem cells, nSCP was cytocompatible up to 1 mg/ml and induced robust mineralisation in the absence of chemical osteogenic induction, outperforming conventional hydroxyapatite/β-tricalcium phosphate. Multivariate profiling of 748 metabolic genes revealed a distinct nSCP-specific transcriptional signature, including marked upregulation of the monocarboxylate transporter SLC16A6, and a secretome enriched in VEGF, angiogenin, uPAR and GDF-15 that significantly enhanced endothelial network formation. In a porcine mandibular defect model, nSCP-containing type I collagen scaffolds increased bone-volume gain, promoted mineralization recovery close to that of native trabecular bone, and improved histological matrix organization after eight weeks compared with controls. Together, these findings indicate that nSCP promotes bone regeneration through combined osteogenic and proangiogenic effects, supporting template-assisted mesoporous silicate–calcium phosphate bioceramics as promising platforms for bone-regeneration biomaterials.

  • Open Access

    Forskolin Enhances Urokinase Plasminogen Activator Secretion and Angiogenic Activity of Xeno‐Free Cultures of Human Adipose Tissue‐Derived Stem Cells

    by Maria Vittoria Giraudo, Anne Therese Lauvrud, Rebecca Wiberg, Maria Brohlin, Gustav Andersson, Paul J Kingham

    Adipose tissue‐derived stem cells (ASCs) hold significant potential for treating various clinical conditions. To enhance their regenerative properties, ASCs can be chemically stimulated using various in vitro protocols. However, unsatisfactory results persist, partly due to the relatively costly long‐term methods. Furthermore, current culturing techniques often rely on the use of xenogenic fetal bovine serum that can be immunogenic, limiting clinical translations. To facilitate clinical translation of ASCs‐derived therapeutics, the effect of different stimulation protocols on human ASCs cultured in a xeno‐free medium (PRIME‐XV MSC Expansion XSFM) is investigated. The xeno‐free medium was supplemented with stimulants (forskolin (FSK), basic fibroblast growth factor, platelet‐derived growth factor‐AA, neuregulin‐1) in combinations or individually. Stimulation for 72 h in FSK alone, or together with the growth factors, enhanced the production of urokinase plasminogen activator (uPA), a serine protease involved in tissue remodeling processes. Conditioned medium derived from stimulated ASCs enhanced in vitro angiogenesis and endothelial cells migration. This study shows that pro‐angiogenic responses in human ASCs can be enhanced with a defined short stimulation protocol using a xeno‐free medium. The protocol, using readily available manufacturing cell therapy grade molecules, may boost the regenerative properties of ASCs secretome which could enhance their efficacy in clinical treatments.

  • Open Access

    Secretome from myoblasts statically loaded at low intensity promotes tenocyte proliferation via the IGF ‐1 receptor pathway

    by Junhong Li, Xin Zhou, Jialin Chen, Pernilla Eliasson, Paul J. Kingham, Ludvig J. Backman

    Exercise is widely recognized as beneficial for tendon healing. Recently, it has been described that muscle‐derived molecules secreted in response to static exercise influence tendon healing. In this study, the optimal static loading intensity for tendon healing and the composition of secretome released by myoblasts in response to different intensities of static strain were investigated. In an in vitro coculture model, myoblasts were mechanically loaded using a Flexcell Tension System. Tenocytes were seeded on transwell inserts that allowed communication between the tenocytes and myoblasts without direct contact. Proliferation and migration assays, together with RNA sequencing, were used to determine potential cellular signaling pathways. The secretome from myoblasts exposed to 2% static loading increased the proliferation and migration of the cocultured tenocytes. RNA‐seq analysis revealed that this loading condition upregulated the expression of numerous genes encoding secretory proteins, including insulin‐like growth factor‐1 (IGF‐1). Confirmation of IGF‐1 expression and secretion was carried out using qPCR and enzyme‐linked immunosorbt assay (ELISA), revealing a statistically significant upregulation in response to 2% static loading in comparison to both control conditions and higher loading intensities of 5% and 10%. Addition of an inhibitor of the IGF‐1 receptor (PQ401) to the tenocytes significantly reduced myoblast secretome‐induced tenocyte proliferation. In conclusion, IGF‐1 may be an important molecule in the statically loaded myoblast secretome, which is responsible for influencing tenocytes during exercise‐induced healing.


  • Open Access

    Efficacy of Nerve-Derived Hydrogels to Promote Axon Regeneration Is Influenced by the Method of Tissue Decellularization

    by Vijay Kumar Kuna, Andre Lundgren, Luis Oliveros Anerillas, Peyman Kelk, Maria Brohlin, Mikael Wiberg, Paul J. Kingham, Ludmila N. Novikova, Gustav Andersson, Lev N. Novikov

    Injuries to large peripheral nerves are often associated with tissue defects and require reconstruction using autologous nerve grafts, which have limited availability and result in donor site morbidity. Peripheral nerve-derived hydrogels could potentially supplement or even replace these grafts. In this study, three decellularization protocols based on the ionic detergents sodium dodecyl sulfate (P1) and sodium deoxycholate (P2), or the organic solvent tri-n-butyl phosphate (P3), were used to prepare hydrogels. All protocols resulted in significantly decreased amounts of genomic DNA, but the P2 hydrogel showed the best preservation of extracellular matrix proteins, cytokines, and chemokines, and reduced levels of sulfated glycosaminoglycans. In vitro P1 and P2 hydrogels supported Schwann cell viability, secretion of VEGF, and neurite outgrowth. Surgical repair of a 10 mm-long rat sciatic nerve gap was performed by implantation of tubular polycaprolactone conduits filled with hydrogels followed by analyses using diffusion tensor imaging and immunostaining for neuronal and glial markers. The results demonstrated that the P2 hydrogel considerably increased the number of axons and the distance of regeneration into the distal nerve stump. In summary, the method used to decellularize nerve tissue affects the efficacy of the resulting hydrogels to support regeneration after nerve injury.


  • Extracellular Vesicles for Nerve Regeneration

    by Gustav Andersson, Paul J. Kingham

  • Open Access

    Three-Dimensional Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Promotes Matrix Metallopeptidase 13 (MMP13) Expression in Type I Collagen Hydrogels

    by Luis Oliveros Anerillas, Paul J. Kingham, Mikko J. Lammi, Mikael Wiberg, Peyman Kelk

    Autologous bone transplantation is the principal method for reconstruction of large bone defects. This technique has limitations, such as donor site availability, amount of bone needed and morbidity. An alternative to this technique is tissue engineering with bone marrow-derived mesenchymal stem cells (BMSCs). In this study, our aim was to elucidate the benefits of culturing BMSCs in 3D compared with the traditional 2D culture. In an initial screening, we combined BMSCs with four different biogels: unmodified type I collagen (Col I), type I collagen methacrylate (ColMa), an alginate and cellulose-based bioink (CELLINK) and a gelatin-based bioink containing xanthan gum (GelXA-bone). Col I was the best for structural integrity and maintenance of cell morphology. Osteogenic, adipogenic, and chondrogenic differentiations of the BMSCs in 2D versus 3D type I collagen gels were investigated. While the traditional pellet culture for chondrogenesis was superior to our tested 3D culture, Col I hydrogels (i.e., 3D) favored adipogenic and osteogenic differentiation. Further focus of this study on osteogenesis were conducted by comparing 2D and 3D differentiated BMSCs with Osteoimage® (stains hydroxyapatite), von Kossa (stains anionic portion of phosphates, carbonates, and other salts) and Alizarin Red (stains Ca2+ deposits). Multivariate gene analysis with various covariates showed low variability among donors, successful osteogenic differentiation, and the identification of one gene (matrix metallopeptidase 13, MMP13) significantly differentially expressed in 2D vs. 3D cultures. MMP13 protein expression was confirmed with immunohistochemistry. In conclusion, this study shows evidence for the suitability of type I collagen gels for 3D osteogenic differentiation of BMSCs, which might improve the production of tissue-engineered constructs for treatment of bone defects.


  • Open Access

    Secretome from In Vitro Mechanically Loaded Myoblasts Induces Tenocyte Migration, Transition to a Fibroblastic Phenotype and Suppression of Collagen Production

    by Xin Zhou, Junhong Li, Antonios Giannopoulos, Paul J. Kingham, Ludvig J. Backman

    It is known that mechanical loading of muscles increases the strength of healing tendon tissue, but the mechanism involved remains elusive. We hypothesized that the secretome from myoblasts in co-culture with tenocytes affects tenocyte migration, cell phenotype, and collagen (Col) production and that the effect is dependent on different types of mechanical loading of myoblasts. To test this, we used an in vitro indirect transwell co-culture system. Myoblasts were mechanically loaded using the FlexCell® Tension system. Tenocyte cell migration, proliferation, apoptosis, collagen production, and several tenocyte markers were measured. The secretome from myoblasts decreased the Col I/III ratio and increased the expression of tenocyte specific markers as compared with tenocytes cultured alone. The secretome from statically loaded myoblasts significantly enhanced tenocyte migration and Col I/III ratio as compared with dynamic loading and controls. In addition, the secretome from statically loaded myoblasts induced tenocytes towards a myofibroblast-like phenotype. Taken together, these results demonstrate that the secretome from statically loaded myoblasts has a profound influence on tenocytes, affecting parameters that are related to the tendon healing process.


  • Extracellular Vesicles for Nerve Regeneration

    by Gustav Andersson, Paul J. Kingham

  • Open Access

    Hyaluronic Acid (HA) Receptors and the Motility of Schwann Cell(-Like) Phenotypes

    by Sihem Ouasti, Alessandro Faroni, Paul J. Kingham, Matilde Ghibaudi, Adam J. Reid, Nicola Tirelli

    The cluster of differentiation 44 (CD44) and the hyaluronan-mediated motility receptor (RHAMM), also known as CD168, are perhaps the most studied receptors for hyaluronic acid (HA); among their various functions, both are known to play a role in the motility of a number of cell types. In peripheral nerve regeneration, the stimulation of glial cell motility has potential to lead to better therapeutic outcomes, thus this study aimed to ascertain the presence of these receptors in Schwann cells (rat adult aSCs and neonatal nSCs) and to confirm their influence on motility. We included also a Schwann-like phenotype (dAD-MSCs) derived from adipose-derived mesenchymal stem cells (uAD-MSCs), as a possible basis for an autologous cell therapy. CD44 was expressed similarly in all cell types. Interestingly, uAD-MSCs were RHAMM(low), whereas both Schwann cells and dASCs turned out to be similarly RHAMM(high), and indeed antibody blockage of RHAMM effectively immobilized (in vitro scratch wound assay) all the RHAMM(high) Schwann(-like) types, but not the RHAMM(low) uAD-MSCs. Blocking CD44, on the other hand, affected considerably more uAD-MSCs than the Schwann(-like) cells, while the combined blockage of the two receptors immobilized all cells. The results therefore indicate that Schwann-like cells have a specifically RHAMM-sensitive motility, where the motility of precursor cells such as uAD-MSCs is CD44- but not RHAMM-sensitive; our data also suggest that CD44 and RHAMM may be using complementary motility-controlling circuits.


  • Open Access

    Combiningin silicoandin vitromodels to inform cell seeding strategies in tissue engineering

    by R. Coy, G. Al-Badri, C. Kayal, C. O'ROurke, P. J. Kingham, J. B. Phillips, R. J. Shipley

    The seeding density of therapeutic cells in engineered tissue impacts both cell survival and vascularization. Excessively high seeded cell densities can result in increased death and thus waste of valuable cells, whereas lower seeded cell densities may not provide sufficient support for the tissuein vivo, reducing efficacy. Additionally, the production of growth factors by therapeutic cells in low oxygen environments offers a way of generating growth factor gradients, which are important for vascularization, but hypoxia can also induce unwanted levels of cell death. This is a complex problem that lends itself to a combination of computational modelling and experimentation. Here, we present a spatio-temporal mathematical model parametrized usingin vitrodata capable of simulating the interactions between a therapeutic cell population, oxygen concentrations and vascular endothelial growth factor (VEGF) concentrations in engineered tissues. Simulations of collagen nerve repair constructs suggest that specific seeded cell densities and non-uniform spatial distributions of seeded cells could enhance cell survival and the generation of VEGF gradients. These predictions can now be tested using targeted experiments.